Literature DB >> 17633069

Morbidity and quality of life following cytoreduction and HIPEC.

M Deraco1, D Baratti, S Kusamura.   

Abstract

Mesh：

Year:  2007        PMID： 17633069     DOI： 10.1007/978-0-387-48993-3_26

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  3 in total

1.  CRS and HIPEC for PMP-Use of the LC-CUSUM to Determine the Number of Procedures Required to Attain a Minimal Level of Proficiency in Delivering the Combined Modality Treatment.

Authors:  Aditi Bhatt; Antony George; Sanket Mehta
Journal:  Indian J Surg Oncol       Date:  2017-08-12

2.  Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Maleen Leimkühler; Judith E K R Hentzen; Patrick H J Hemmer; Lukas B Been; Robert J van Ginkel; Schelto Kruijff; Barbara L van Leeuwen; Geertruida H de Bock
Journal:  Ann Surg Oncol       Date:  2020-04-26       Impact factor: 5.344

3.  ASO Author Reflections: A Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  B L Van Leeuwen; S Kruijff
Journal:  Ann Surg Oncol       Date:  2020-04-07       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.